Accelerating development of genetic therapies for muscular dystrophies
The aim of MAGIC is to accelerate the development of gene therapies and genome editing strategies for muscular dystrophies by creating advanced humanized muscle models and innovative gene therapy approaches, ultimately improving the lives of individuals affected by these debilitating diseases.
Key Objectives
- Creating accurate humanized muscle models.
- Developing precise gene therapies and genome editing strategies.
- Engineering disease-specific muscle-on-chip devices.
- Assessing safety and efficacy of novel gene therapies.
- Exploring gene editing strategies for neuromuscular disorders.
- Facilitating translation and exploitation of project outputs.
- Ensuring patient perspectives remain central to the research.
See how MAGIC is working to reach these key objectives
Latest News
Join the MAGIC Team – recruitment opportunities
Join MAGIC vibrant team - recruiting for: Postdoctoral researcher – Genome editing for inherited muscular disorders @ INSERM-Genethon (FR): deadline 29 February 2024. To know more about this...
MAGIC team kick-off meeting
The MAGIC team has come together in Brussels on 22-23 October 2023 for the official kick-off meeting.
MAGIC consortium participates in the ESGCT 2023 conference
Participants of the MAGIC consortium have participated in the recently concluded ESGCT 2023 conference with poster presentations and talks.